BQ‐123, A Selective Endothelin ETA Receptor Antagonist
- 1 March 1994
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 12 (1), 48-69
- https://doi.org/10.1111/j.1527-3466.1994.tb00283.x
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive modelLife Sciences, 1993
- Endothelin-3-Mediated Proliferation in Wounded Human Umbilical Vein Endothelial CellsBiochemical and Biophysical Research Communications, 1993
- ETA and ETB Receptors Coexist on Rabbit Pulmonary Artery Vascular Smooth Muscle Mediating ContractionBiochemical and Biophysical Research Communications, 1993
- BQ-123 Identifies Heterogeneity and Allosteric Interactions at the Rat Heart Endothelin ReceptorBiochemical and Biophysical Research Communications, 1993
- BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injectionLife Sciences, 1993
- ET-3 sensitive reduction of tissue blood flow in rat liverLife Sciences, 1992
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- The endothelin-A receptor subtype transduces the effects of the endothelins in the anterior pituitary glandBiochemical and Biophysical Research Communications, 1992
- A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptorsLife Sciences, 1992
- An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensisBiochemical and Biophysical Research Communications, 1991